Darbecure 25 MCG Injection 1 ML is used for treating symptomatic anaemia associated with chronic kidney disease. It belongs to the therapeutic class of erythropoiesis-stimulating agents (ESAs), which help increase red blood cell production in the body.
This medication also manages anaemia resulting from chemotherapy treatments in cancer patients. However, it is not used for cancers involving bone marrow or red blood cell malignancies. In patients with kidney failure, the organs fail to produce adequate amounts of erythropoietin, a natural hormone essential for red blood cell production.
The injection must be administered exclusively by qualified healthcare professionals such as doctors or nurses in hospital or clinical settings. You should inform your doctor about any pre-existing conditions like high blood pressure, liver disease, or seizures before beginning this medicine. If you notice any side effects while receiving this medicine, notify your doctor immediately. Continue with the treatment for the duration prescribed by your doctor for optimal results.























































